Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-20T06:31:39.075Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of the neuronal nitric oxide synthase inhibitor 7-nitroindazole on the righting reflex ED50 and minimum alveolar concentration during sevoflurane anaesthesia in rats

Published online by Cambridge University Press:  02 June 2005

S. Kobayashi ,
T. Katoh ,
T. Iwamoto ,
H. Bito  and
S. Sato
S. Kobayashi
Affiliation:
Hamamatsu University School of Medicine, Department of Anesthesiology and Intensive Care, Hamamatsu, Japan
T. Katoh
Affiliation:
Hamamatsu University School of Medicine, Department of Anesthesiology and Intensive Care, Hamamatsu, Japan
T. Iwamoto
Affiliation:
Hamamatsu University School of Medicine, Department of Anesthesiology and Intensive Care, Hamamatsu, Japan
H. Bito
Affiliation:
Hamamatsu University School of Medicine, Department of Anesthesiology and Intensive Care, Hamamatsu, Japan
S. Sato
Affiliation:
Hamamatsu University School of Medicine, Department of Anesthesiology and Intensive Care, Hamamatsu, Japan
Get access

Extract

Summary

Background and objective: The aim was to determine the effect of acute and chronic administration of 7-nitroindazole, a selective neuronal nitric oxide synthase inhibitor, on the righting reflex ED50 and the minimum alveolar concentration during sevoflurane anaesthesia in rats.

Methods: 7-Nitroindazole was acutely (0, 50 and 100 mg kg−1) and chronically (0 and 150 mg kg−1 day−1, 4 days) administered to rats. After the preparation, the minimum alveolar concentration and the righting reflex ED50 were measured. The concentration of cGMP in the brain, cerebellum and spinal cord was also measured.

Results: Acute administration reduced the minimum alveolar concentration (50 mg kg−1, 58.8% (95% CI: 50.3–67.3%) of the baseline value, P < 0.01; 100 mg kg−1, 55.8 (46.9–64.7), P < 0.01) and the righting reflex ED50 (50 mg kg−1, 27.2 (17.2–37.2), P < 0.01; 100 mg kg−1, 14.3 (6.6–22.0), P < 0.01). Chronic administration did not reduce the minimum alveolar concentration; however, it reduced the righting reflex ED50 (65.3 (52.9–77.7), P < 0.01). Overall, the reduction in minimum alveolar concentration in the acute and chronic protocol did not correlate with that of the righting reflex ED50. 7-Nitroindazole (100 mg kg−1, acute) reduced the cGMP concentration within the cerebellum by 55.4%; however, it did not decrease concentrations in the brain or spinal cord.

Conclusions: Different mechanisms are responsible for the observed alterations to the minimum alveolar concentration and the righting reflex ED50 following treatment with 7-nitroindazole. The nitric oxide–cGMP pathway might play a less important role in the determination of minimum alveolar concentration than the righting reflex ED50.

Keywords

ANAESTHETICS, INHALATION, nitrous oxide, sevoflurane
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 20 , Issue 3 , March 2003 , pp. 212 - 219
Copyright
© 2003 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Johns RA, Moscicki JC, DiFazio CA. Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. Anesthesiology 1992; 77: 779–784.Google Scholar
Adachi T, Kurata J, Nakao S, et al. Nitric oxide syn-thase inhibitor does not reduce minimum alveolar concentration of halothane in rats. Anesth Analg 1994; 78: 1154–1157.Google Scholar
Adachi T, Shinomura T, Nakao S, et al. Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity and cyclic guanosine monophosphate but does not modify minimum alveolar anesthetic concentration. Anesth Analg 1995; 81: 862–865.Google Scholar
Ichinose F, Huang PL, Zapol WM. Effects of targeted neuronal nitric oxide synthase gene disruption and nitrog-l-arginine methylester on the threshold for isoflurane anesthesia. Anesthesiology 1995; 83: 101–108.Google Scholar
Ichinose F, Mi WD, Miyazaki M, Onouchi T, Goto T, Morita S. Lack of correlation between the reduction of sevoflurane MAC and the cerebellar cyclic GMP concentration in mice treated with 7-nitroindazole. Anesthesiology 1998; 89: 143–148.Google Scholar
Koblin DD, Deady JE, Eger EI II. Potencies of inhaled anesthetics and alcohol in mice selectively bred for resistance and susceptibility to nitrous oxide anesthesia. Anesthesiology 1982; 56: 18–24.Google Scholar
Crawford MW, Lerman J, Saldivia V, Carmichael FJ. Hemodynamic and organ blood flow responses to halothane and sevoflurane anesthesia during spontaneous ventilation. Anesth Analg 1992; 75: 1000–1006.Google Scholar
Pajewski TN, DiFazio CA, Moscicki JC, Johns RA. Nitric oxide synthase inhibitors, 7-nitro indazole and nitrog-l-arginine methyl ester, dose dependently reduce the threshold for isoflurane anesthesia. Anesthesiology 1996; 85: 1111–1119.Google Scholar
Kant GJ, Muller TW, Lenox RH, Meyerhoff JL. In vivo effects of pentobarbital and halothane anesthesia on levels of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in rat brain regions and pituitary. Biochem Pharmacol 1980; 29: 1891–1896.Google Scholar
Terasako K, Nakamura K, Miyawaki I, Toda H, Kakuyama M, Mori K. Inhibitory effects of anesthetics on cyclic guanosine monophosphate (cGMP) accumulation in rat cerebellar slices. Anesth Analg 1994; 79: 921–926.Google Scholar
Masaki E. Kondo I. Methylene blue, a soluble guanylyl cyclase inhibitor, reduces the sevoflurane minimum alveolar anesthetic concentration and decreases the brain cyclic guanosine monophosphate content in rats. Anesth Analg 1999; 89: 484–489.Google Scholar
Thomson AM, West DC, Lodge D. An N-methylaspartate receptor mediated synapse in rat cerebral cortex: a site of action of ketamine? Nature 1985; 313: 479–481.Google Scholar
Mohler H, Burkard WP, Keller HH, Richards JG, Haefely W. Benzodiazepine antagonist Ro 15-1788; binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels. J Neurochem 1981; 37: 714–722.Google Scholar
Moore PK, Oluyomi AO, Babbedge RC, Wallace P, Hart SL. l-ng-Nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 1991; 102: 198–202.Google Scholar
Malmberg AB, Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 1993; 54: 291–300.Google Scholar
Lothe A, Li P, Tong C, Bouaziz H, Detweiler DJ, Eisenach JC. Spinal cholinergic alpha-2 adrenergic interactions in analgesia and hemodynamic control: role of muscarinic receptor subtypes and nitric oxide. J Pharmacol Exp Ther 1994; 270: 1301–1306.Google Scholar
Xu JY, Tseng LF. Increase of nitric oxide by l-arginine potentiates beta-endorphin- but not mu-, delta- or kappa-opioid agonist-induced antinociception in the mouse. Eur J Pharmacol 1993; 236: 137–142.Google Scholar
Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768–770.Google Scholar
Gaffen Z, Bland-Ward PA, Pitcher A, Wallace P, Moore PK. Augmented antinociception following 7-nitroindazole and flurbiprofen in the conscious mouse. Eur J Pharmacol 1994; 271: 445–452.Google Scholar
Kawamata T, Omote K. Activation of spinal N-methyl-d-aspartate receptors stimulates a nitric oxide/cyclic guanosine 3′,5′-monophosphate/glutamate release cascade in nociceptive signaling. Anesthesiology 1999; 91: 1415–1424.Google Scholar
Rampil IJ, Mason P, Singh H. Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology 1993; 78: 707–712.Google Scholar
Rampil IJ. Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology 1994; 80: 606–610.Google Scholar
Antognini JF, Schwartz K. Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology 1993; 79: 1244–1249.Google Scholar
Borges M, Antognini JF. Dose the brain influence somatic responses to noxious stimuli during isoflurane anesthesia? Anesthesiology 1994; 81: 1511–1515.Google Scholar
Katoh T, Kobayashi S, Suzuki A, Iwamoto T, Bito H, Ikeda K. The effect of fentanyl on sevoflurane requirements for somatic and sympathetic responses to surgical incision. Anesthesiology 1999; 90: 398–405.Google Scholar
Dun NJ, Dun SL, Wu SY, et al. Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience 1993; 54: 845–857.Google Scholar
Fukuda T, Saito S, Sato S, Harukuni I, Toyooka H. Halothane minimum alveolar anesthetic concentration and neuronal nitric oxide synthase activity of the dorsal horn and the locus ceruleus in rats. Anesth Analg 1999; 89: 1035–1039.Google Scholar